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Mesothelioma is a rare pulmonary malignancy commonly associated with asbestos exposure. Its pre-
sentation is insidious and non-speciﬁc, with complaints of chest pain, dyspnea and cough. Chest X-ray
may demonstrate unilateral pleural effusion. CT and PET scans may highlight nodular pleural plaques.
Diagnosis often times is difﬁcult with negative imaging and negative pleural ﬂuid studies. In rare cases,
hydropneumothoraces may be seen. We report a case of malignant pleural mesothelioma presenting as
recurrent hydropneumothorax with negative CT scan of the chest for pleural abnormalities and negative
pleural ﬂuid studies.
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mesothelioma is a rare (1% of all cancers) and lethal disease
with a median survival of 9e17 months. It is most commonly
associated with asbestos exposure [1,2]. Currently, there are about
2500 cases per year in the US. While the incidence has stabilized,
it is on the rise in other countries [3]. It is typically diagnosed after
patients present with nonspeciﬁc symptoms of chest pain, dys-
pnea, and cough with initial imaging most commonly showing
unilateral pleural effusion. The combination of nonspeciﬁc symp-
toms and imaging ﬁndings can make mesothelioma a diagnostic
dilemma. This case highlights the unusual ways in which meso-
thelioma can present, and the importance of a thorough history
taking and the necessity for further investigation with recurrence
of hydropneumothoraces or unilateral pleural effusions.
2. Case
A 67 year-old male with a history of hypertension and hyper-
lipidemia presented to his primary care provider with dyspnea
and productive cough for two weeks. He denied weight loss, fe-
vers, or hemoptysis. He was a former cigarette smoker who served
four years in the Navy about 40 years ago. Vitals signs and physicalapp), ca.chan87@gmail.com
r Ltd. This is an open access articleexam, including breath sounds, were normal. Initial chest X-ray
revealed a right hydropneumothorax. Right tube thoracostomy
and doxycycline pleurodesis were performed during a short hos-
pital admission. Approximately 1.5 L of exudative pleural ﬂuid was
removed, but cytology was negative for malignant cells. He
returned eight months later with progressive dyspnea, orthopnea,
and cough. Chest X-ray and CT of the thorax showed a large right
pleural effusion without pleural abnormalities (Fig. 1). A diagnostic
and therapeutic right-sided thoracentesis was notable for exuda-
tive pleural ﬂuid which was again unremarkable for malignant
cells. A PET/CT scan was negative. He returned to the hospital two
more times over the next two weeks for dyspnea and found to
have a right-sided pleural effusion on CT scan of thorax (Fig. 2)
followed by recurrence of right hydropneumothorax on chest X-
ray (Fig. 3). Further investigation included a thoracoscopy and
pleural biopsy, which demonstrated a diffuse micronodular and
visceral pleura. Pathology showed epithelioid mesothelioma that
was involving the visceral pleura and was staged T2 N2 M0.
Subsequently, he had mediastinoscopy, extrapleural pneumonec-
tomy, right pericardiectomy, and right hemidiaphragm removal
and reconstruction followed by chemoradiation. The patient did
well for about 1 year until he returned with a right hydrothorax
and passed away a few months later.3. Discussion
This case highlights the difﬁculties in diagnosing malignantunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
Fig. 1. Initial chest X-ray demonstrating a right hydropneumothorax.
Fig. 2. CT of the thorax during third hospital visit demonstrating right unilateral
pleural effusion without pleural abnormalities.
Fig. 3. Chest X-ray during last hospital visit demonstrating a recurrent right
hydropneumothorax.
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imaging studies. Not only did the patient present with non-
speciﬁc symptoms, but the initial CT scan did not show any
pleural abnormality, and pleural ﬂuid analysis was negative for
malignant cells. Few case reports have noted recurrent hydro-
pneumothorax as the only presenting feature of mesothelioma
[4e9].
Patients with mesothelioma typically present with a history of
asbestosis exposure, which highlights the importance of a thorough
history, as greater than 90% of cases have an association with
asbestosis [1]. There is typically a latency period of 15e60 years
from exposure, and patients are typically diagnosed at ages 50e70
years old [10]. Patients typically present with symptoms of chest
pain and/or dyspnea that develop over time. Physical exam is
nonspeciﬁc with signs of a pleural effusion being the onlycontributing ﬁnding. Pleural ﬂuid is only positive in 30% of cases
[1]. It is fairly common for mesothelioma to present with a pleural
effusion as up to 80% of patients present with a unilateral pleural
effusion [2,11,12]. Spontaneous primary pneumothoraces are also
fairly common with an incidence of 18e28/100,000 men; however
only 0.02% are associated with malignancy [13]. In a small case
series of mesothelioma patients, 11% of patients presented with
pneumothoraces [14]. There is little to no data on hydro-
pneumothoraces as the presenting feature of malignant mesothe-
lioma. The mechanism of hydropneumothorax is unclear. One
popular theory is that it is caused by the rupture of necrotic tumor
nodules [15].
Other imaging modalities can be more revealing, but no single
imaging diagnostic tool should be used in patients with risk factors
and high suspicion. Chest X-rays can show pleural masses or
thickening in 45e60% of cases [16]. Pleural changes on CT chest
have been noted to have up to 90%e95% sensitivity [12,17e19]. PET
scans have been shown to have a 96.8% sensitivity and 88.5%
speciﬁcity for distinguishing malignant disease and are typically
only used for staging [20]. There were no easily notable pleural
features initially on imaging in our patient despite the high sensi-
tivity of the CT and PET/CT scan making this case even more
unusual.
Mesothelioma presents nonspeciﬁcally and in this case uniquely
as a hydropneumothorax making diagnosis difﬁcult. The case
demonstrates the importance of early invasive testing with recur-
rence of hydropneumothoraces or unilateral pleural effusions
despite negative imaging and negative pleural ﬂuid studies. Pleural
biopsy may be necessary early in the workup in recurrent hydro-
pneumothoraces or unilateral pleural effusions in elderly with a
history of asbestos exposure.Conﬂicts of interest
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